{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:00:47Z","timestamp":1793235647020,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalimaging.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Imaging"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.clinimag.2015.07.027","type":"journal-article","created":{"date-parts":[[2015,7,26]],"date-time":"2015-07-26T11:22:05Z","timestamp":1437909725000},"page":"573-580","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["What do we know about brain contrast enhancement patterns in neuromyelitis optica?"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1421-3376","authenticated-orcid":false,"given":"Yeliz","family":"Pekcevik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunes","family":"Orman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8967-6338","authenticated-orcid":false,"given":"Maureen A.","family":"Mealy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izlem","family":"Izbudak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinimag.2015.07.027_bb0005","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00415-013-7169-7","article-title":"Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS)","volume":"261","author":"Trebst","year":"2014","journal-title":"J Neurol"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0015","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00234-011-0875-x","article-title":"Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?","volume":"54","author":"Downer","year":"2012","journal-title":"Neuroradiology"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0020","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/archneurol.2010.188","article-title":"Interferon beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers","volume":"67","author":"Palace","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0025","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s00415-013-6965-4","article-title":"Natalizumab and the development of extensive brain lesions in neuromyelitis optica","volume":"260","author":"Jury\u0144czyk","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0030","first-page":"14","article-title":"Magnetic resonance imaging in neuromyelitis optica","author":"Tackley","year":"2014","journal-title":"Mult Scler"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0035","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0040","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/archneur.63.3.390","article-title":"Brain abnormalities in neuromyelitis optica","volume":"63","author":"Pittock","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0045","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic's syndrome)","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0050","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nic.2012.12.007","article-title":"Diagnosing neuromyelitis optica","volume":"23","author":"Makhani","year":"2013","journal-title":"Neuroimaging Clin N Am"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0055","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejrad.2010.06.024","article-title":"Brain MRI abnormalities in neuromyelitis optica","volume":"80","author":"Wang","year":"2011","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0060","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1468-1331.2011.03565.x","article-title":"Conventional brain MRI in neuromyelitis optica","volume":"19","author":"Cabrera-Gomez","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0065","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/WNL.0b013e3182887957","article-title":"Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution","volume":"80","author":"Matthews","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0070","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1016\/j.ejrad.2012.02.010","article-title":"MR imaging findings of the corpus callosum region in the differentiation between multiple sclerosis and neuromyelitis optica","volume":"81","author":"Chen","year":"2012","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0075","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1212\/WNL.0b013e318214332c","article-title":"Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications","volume":"76","author":"Popescu","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0080","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/ana.22121","article-title":"Intractable vomiting as the initial presentation of neuromyelitis optica","volume":"68","author":"Apiwattanakul","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0085","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00415-009-0139-4","article-title":"Narcolepsy as an initial manifestation of neuromyelitis optica with anti-aquaporin-4 antibody","volume":"256","author":"Baba","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0090","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1212\/01.wnl.0000314832.24682.c6","article-title":"CNS aquaporin-4 autoimmunity in children","volume":"71","author":"McKeon","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0095","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3344\/kjp.2014.27.1.77","article-title":"A case of neuromyelitis optica misdiagnosed as cervicogenic headache","volume":"27","author":"Choi","year":"2014","journal-title":"Korean J Pain"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0100","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/archneurol.2007.59","article-title":"Acute disseminating encephalomyelitis in neuromyelitis optica: closing the floodgates","volume":"65","author":"Eichel","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0105","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.21753","article-title":"\"Cloud-like enhancement\" is a magnetic resonance imaging abnormality specific to neuromyelitis optica","volume":"66","author":"Ito","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0110","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1177\/1352458509106613","article-title":"Extensive vasogenic edema of anti-aquaporin-4 antibody-related brain lesions","volume":"15","author":"Matsushita","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0115","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/01.wnl.0000343001.36493.ae","article-title":"Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders","volume":"72","author":"Maga\u00f1a","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0120","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1177\/1352458510376640","article-title":"Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity","volume":"16","author":"Kim","year":"2010","journal-title":"Mult Scler"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jns.2010.12.001","article-title":"Brain abnormalities in neuromyelitis optica","volume":"302","author":"Kim","year":"2011","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0130","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1177\/1352458511404917","article-title":"Brain abnormalities as an initial manifestation of neuromyelitis optica spectrum disorder","volume":"17","author":"Kim","year":"2011","journal-title":"Mult Scler"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0135","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1212\/WNL.0b013e3182242d6e","article-title":"Fulminant cerebral demyelination in neuromyelitis optica","volume":"77","author":"Newey","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0140","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1111\/j.1468-1331.2012.03667.x","article-title":"Cortical and leptomeningeal involvement in three cases of neuromyelitis optica","volume":"19","author":"Tahara","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0145","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1111\/j.1468-1331.2012.03696.x","article-title":"Acute reversible periependymal ventricular enhancement in neuromyelitis optica","volume":"19","author":"McGraw","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0150","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1177\/1352458511431730","article-title":"Pencil-thin ependymal enhancement in neuromyelitis optica spectrum disorders","volume":"18","author":"Banker","year":"2012","journal-title":"Mult Scler"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0155","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1471-2377-13-72","article-title":"Clinical, radiographic characteristics and immunomodulating changes in neuromyelitis optica with extensive brain lesions","volume":"13","author":"Cheng","year":"2013","journal-title":"BMC Neurol"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0160","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1007\/s00415-013-6997-9","article-title":"Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies","volume":"260","author":"Iorio","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0165","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/1352458513506953","article-title":"The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders","volume":"20","author":"Huh","year":"2014","journal-title":"Mult Scler"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0170","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jneuroim.2014.02.006","article-title":"Brain gadolinium enhancement along the ventricular and leptomeningeal regions in patients with aquaporin-4 antibodies in cerebral spinal fluid","volume":"269","author":"Long","year":"2014","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0175","article-title":"Perivascular enhancement in a patient with neuromyelitis optica spectrum disease during an optic neuritis attack","author":"Pekcevik","year":"2014","journal-title":"J Neuroimaging"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0180","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3174\/ajnr.A0725","article-title":"Exceeding the limits of the normal blood\u2013brain barrier: quo vadis gadolinium?","volume":"28","author":"Levy","year":"2007","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0185","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/brain\/awm047","article-title":"Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis","volume":"130","author":"Misu","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0190","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":"A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica","volume":"125","author":"Lucchinetti","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0195","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic\u2013spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0200","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/archneur.63.7.964","article-title":"Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression","volume":"63","author":"Pittock","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0205","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1177\/1352458513499420","article-title":"Comparison of deep gray matter lesions on magnetic resonance imaging among adults with acute disseminated encephalomyelitis, multiple sclerosis, and neuromyelitis optica","volume":"20","author":"Zhang","year":"2014","journal-title":"Mult Scler"},{"key":"10.1016\/j.clinimag.2015.07.027_bb0210","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/WNO.0b013e318254c62d","article-title":"Magnetic resonance imaging of optic neuritis in patients with neuromyelitis optica versus multiple sclerosis","volume":"32","author":"Khanna","year":"2012","journal-title":"J Neuroophthalmol"}],"container-title":["Clinical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707115002065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707115002065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T12:57:50Z","timestamp":1537448270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899707115002065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0899707115002065"],"URL":"https:\/\/doi.org\/10.1016\/j.clinimag.2015.07.027","relation":{},"ISSN":["0899-7071"],"issn-type":[{"value":"0899-7071","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What do we know about brain contrast enhancement patterns in neuromyelitis optica?","name":"articletitle","label":"Article Title"},{"value":"Clinical Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinimag.2015.07.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}